OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
XYF X Financial
FNWB First Northwest Bancorp
NIO NIO Inc
MSFT Microsoft Corp
LMT Lockheed Martin Corp
DD Dupont De Nemours Inc
DOW Dow Inc
CTVA Corteva Inc
CSCO Cisco Systems Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

OraSure Technologies, Inc. (OraSure) is a medical device company that develops, manufactures, and markets medical devices and diagnostic products. The Company's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

Postmarket

Last Trade
Delayed
$10.92
0.07 (0.65%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$10.85
Day's Change
-0.03 (-0.28%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
10.95
Day's Low
10.65
Volume
(Light)
Volume:
359,833

10-day average volume:
472,968
359,833

OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

4:01 pm ET July 27, 2021 (Globe Newswire) Print

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, August 3, 2021.

August 3, 2021 Schedule:

4:01 p.m. ET - 2021 second quarter financial results press release will be distributed.

4:50 p.m. ET - To participate in the conference call, dial (888) 771-4371 (Domestic) or (847) 585-4405 (International) and reference Conference ID # 50205303.

5:00 p.m. ET - Conference call and simultaneous Webcast begins.

The conference call will also be available via webcast, and may be accessed on the Investor Relations page of OraSure's website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access, 10 minutes prior to the call.

If you are unable to participate, a replay of the call will be archived on OraSure's website shortly after the call has ended and will be available for 14 days. A replay of the call can also be accessed until midnight, August 17, 2021 by dialing (855) 859-2056 (Domestic) or (404) 537-3406 (International) and entering the Conference ID # 50205303.

Investor Contact:                                 Media Contact:
Scott Gleason                                     Amy Koch
SVP Investor Relations & Corporate Communications Sr. Mgr. Corporate Communications
484-425-0588                                      484-523-1815
sgleason@orasure.com                              media@orasure.com

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

comtex tracking

COMTEX_390520902/2010/2021-07-27T16:01:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.